Outlook Therapeutics (OTLK) Current Leases (2015 - 2023)
Outlook Therapeutics (OTLK) recorded Current Leases of $1,084 in fiscal Q1 2024 (quarter ended Dec 31, 2023), down 91.1% from $12,137 a year earlier and down 74.6% from the prior quarter.
Outlook Therapeutics (OTLK) Current Leases (2015 - 2023) Analysis & Trends
At the end of FY2023 (ended Sep 30, 2023), Outlook Therapeutics reported Current Leases of $4,267, down 63.7% from FY2022.
- Annual Current Leases has declined for five straight fiscal years, with a five-year compound annual growth rate of -61.7% (FY2018 to FY2023).
- Across earlier fiscal years, Current Leases came in at $11,751 in FY2022 (-55.6%), $26,464 in FY2021 (-11.1%), $29,778 in FY2020 (-84.5%) and $192,290 in FY2019 (-63.1%).
- The fiscal Q1 2024 figure is the lowest quarterly Current Leases in data going back to fiscal Q4 2015.
- On a year-over-year basis, Current Leases has declined for 20 consecutive quarters, with an average decline of 53.6% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Leases ran from 11.1% in fiscal Q4 2021 to 91.1% in fiscal Q1 2024.
- Per Business Quant, the preceding three fiscal quarters came in at $4,267 (Q4 2023), $7,349 (Q3 2023) and $10,332 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.26 Bn | 1,105.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 618.12 Bn | 536.65 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.25 Bn | 476.36 Bn | 12.70 Bn | - |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.45 Bn | 262.44 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.30 Bn | 192.70 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.35 Bn | 165.55 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.92 Bn | 116.56 Bn | 10.94 Bn | - |
| 10 | Outlook Therapeutics | 77.31 Mn | 41.56 Mn | -8,265.00 | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1,084.00 |
| Sep 30, 2023 | 4,267.00 |
| Jun 30, 2023 | 7,349.00 |
| Mar 31, 2023 | 10,332.00 |
| Dec 31, 2022 | 12,137.00 |
| Sep 30, 2022 | 11,751.00 |
| Jun 30, 2022 | 14,354.00 |
| Mar 31, 2022 | 18,422.00 |
| Dec 31, 2021 | 22,460.00 |
| Sep 30, 2021 | 26,464.00 |
| Jun 30, 2021 | 27,459.00 |
| Mar 31, 2021 | 26,972.00 |
| Dec 31, 2020 | 26,498.00 |
| Sep 30, 2020 | 29,778.00 |
| Jun 30, 2020 | 41,213.00 |
| Mar 31, 2020 | 52,851.00 |
| Dec 31, 2019 | 172,609.00 |
| Sep 30, 2019 | 192,290.00 |
| Jun 30, 2019 | 205,413.00 |
| Mar 31, 2019 | 217,949.00 |
Outlook Therapeutics Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=OTLK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();